Press release
Obesity Market Size was USD 1,052 Million in 2021
Key takeaways from the Obesity Market Research Report
• Total prevalent cases of obesity in adults (>19 years) were 182.22 Million (M) and in children (5-19 years) were 7.85 million in the 7MM which are expected to grow during the study period, i.e., 2019-2032.
• In 2021, the total Obesity market size was USD 1,052 million which is expected to rise during the study period (2019-2032).
• Obesity Market Companies are working such as Novo Nordisk, Eli Lilly and Company, MedImmune, Boehringer Ingelheim, Raziel Therapeutics, Altimmune, Saniona, YSOPIA Bioscience, Innovent Biologics, Glaceum, Shionogi, Aardvark Therapeutics, NuSirt Biopharma, Novartis, CSPC Baike (Shandong) Biopharmaceutical, Jiangsu HengRui Medicine, Carmot Therapeutics, Pfizer, Sciwind Biosciences, Empros Pharma and others.
• Obesity Pipeline therapies include VI-0521, THR-4109, topiramate, phentermine, PF-06882961, Rosuvastatin, Midazolam, Tesofensine and others.
To read more about the latest drug development related to Obesity, get a snapshot of the key highlights included in the Obesity Market Outlook @ https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Obesity Overview
Obesity is a complicated condition characterized by an excess of body fat. Obesity is more than simply an aesthetic issue. It is a medical condition that raises the risk of developing other diseases and health issues, such as heart disease, diabetes, high blood pressure, and some malignancies. Some people struggle to lose weight for a variety of reasons. Obesity is typically caused by a combination of genetic, physiological, and environmental variables, as well as dietary, physical activity, and exercise decisions.
Obesity Epidemiology Segmentation in the 7MM
• Total Obesity Prevalent Cases
• Total Obesity Patients Seeking Help
• Total Obesity Treated Cases
To know more about the Obesity drugs market growth, get a snapshot of the report Obesity Market Analysis Report @ https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Obesity Treatment Market
Losing weight through healthy eating, increasing physical activity, and making other lifestyle changes are all common therapies for obesity. Some people may benefit from weight-management programs in order to lose weight or avoid regaining it. Some obese persons are either unable to drop enough weight to enhance their health or are unable to maintain their weight loss. Other therapies, such as weight-loss drugs, gadgets, or bariatric surgery, may be considered in such circumstances.
Within the first 6 months of treatment, it is recommended to decrease 5-10% of the body weight. It can help reduce the risk of developing obesity-related health problems, and improve health conditions associated with obesity, such as high blood pressure and high cholesterol levels. So obesity can be managed by reducing calories and adopting healthier eating habits, physical activity, and weight loss medications like orlistat and phentermine.
Obesity Companies and Pipeline Therapies
• Novo Nordisk: VI-0521
• Eli Lilly and Company: THR-4109
• MedImmune: topiramate
• Boehringer Ingelheim: phentermine
• Raziel Therapeutics: PF-06882961
• Altimmune: Rosuvastatin
• Saniona: Midazolam
• YSOPIA Bioscience: Tesofensine
Get a sneak peek at the Obesity Market Dynamics @ https://www.delveinsight.com/sample-request/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Obesity Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Forecast Period- 2022-2032
• Obesity Companies- Novo Nordisk, Eli Lilly and Company, MedImmune, Boehringer Ingelheim, Raziel Therapeutics, Altimmune, Saniona, YSOPIA Bioscience, Innovent Biologics, Glaceum, Shionogi, Aardvark Therapeutics, NuSirt Biopharma, Novartis, CSPC Baike (Shandong) Biopharmaceutical, Jiangsu HengRui Medicine, Carmot Therapeutics, Pfizer, Sciwind Biosciences, Empros Pharma and others
• Obesity Pipeline therapies- VI-0521, THR-4109, topiramate, phentermine, PF-06882961, Rosuvastatin, Midazolam, Tesofensine and others
• Obesity Market Drivers and Barriers, Unmet Needs
Read more about the Obesity treatment market report @ https://www.delveinsight.com/sample-request/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Obesity Report Introduction
3. Obesity Market Overview at a Glance
4. Key Events
5. Epidemiology and Market Methodology
6. Disease Background and Overview
7. Obesity Diagnosis
8. Treatment and Management
9. Epidemiology and Patient Population
10. Obesity: Country-wise Epidemiology
11. Patient Journey
12. Obesity Marketed Therapies
13. Emerging Obesity Therapies
14. Conjoint Analysis
15. Obesity: 7 Major Market Analysis
16. Reimbursement and Market access
17. KOL Views
18. Obesity Market Drivers
19. Obesity Market Barriers
20. SWOT Analysis
21. Unmet Needs
22. Appendix
23. DelveInsight Capabilities
24. Disclaimer
25. About DelveInsight
Learn more about the Obesity Market Drivers and Barriers @ https://www.delveinsight.com/sample-request/weight-loss-weight-management-obesity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Company Name: DelveInsight LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 09193216187
Address: 304 S. Jones Blvd #2432,
City: Las Vegas
State: United States
Country: India
Website: https://www.delveinsight.com/
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Obesity Market Size was USD 1,052 Million in 2021 here
News-ID: 2834201 • Views: …
More Releases from DelveInsight Business Research
NLRP3 Protein Inhibitors Pipeline Expands With 20+ Companies Advancing 25+ Thera …
DelveInsight's latest publication, "NLRP3 Protein Inhibitors Pipeline Insight 2025," presents an in-depth evaluation of more than 20 companies and 25 investigational therapies advancing within the NLRP3 Protein Inhibitors development landscape. The report features detailed profiles of both clinical- and preclinical-stage candidates, along with an assessment of therapeutic approaches by product category, development phase, route of administration, and molecule type. Additionally, the analysis highlights inactive or discontinued programs in this domain.
Explore…
Global Clostridium Difficile Infections Pipeline Expands With 20+ Companies Adva …
DelveInsight's report, "Clostridium Difficile Infections Pipeline Insight, 2025," delivers an extensive overview of the current clinical development status and future growth opportunities within the CDI market.
The report offers a comprehensive commercial and clinical analysis of pipeline therapies, spanning from preclinical stages to marketed products. It includes detailed drug profiles covering mechanisms of action, clinical data, regulatory milestones, and product development updates such as technological innovations, collaborations, mergers and acquisitions, funding…
Global Urticaria Pipeline Expands With 20+ Companies Advancing 25+ Therapies, Re …
DelveInsight's "Urticaria Pipeline Insight, 2025" report provides an in-depth overview of the current landscape of clinical development and future growth potential within the Urticaria market.
The report delivers a comprehensive commercial and clinical analysis of pipeline therapies, spanning preclinical research to marketed products. It offers detailed drug profiles covering mechanisms of action, clinical study updates, regulatory milestones, and product development activities, including technology platforms, partnerships, collaborations, acquisitions, funding, designations, and other…
Global Neurofibromatosis Type 2 Pipeline Expands With 5+ Companies Advancing 5+ …
According to DelveInsight's analysis, the global Neurofibromatosis Type 2 (NF2) pipeline consists of more than five leading companies actively advancing over five therapeutic candidates. The assessment includes a comprehensive review of ongoing clinical trials, therapy mechanisms, routes of administration, and recent development activities.
DelveInsight's "Neurofibromatosis Type 2 Pipeline Insight, 2025" report delivers an extensive overview of the current clinical landscape and future growth potential across the Neurofibromatosis Type 2 market. The…
More Releases for Obesity
Anti-Obesity Drugs Market Grows Rapidly, Driven by Obesity Rates and Therapeutic …
Anti-Obesity Drugs Market valued at USD 5.9 Bn in 2024, growing at 16.5% CAGR to reach USD 20.02 Bn by 2032. Driven by GLP-1 therapies and rising obesity rates.
Anti Obesity Drugs Market Overview:
The anti-obesity drugs market is undergoing significant transformation as awareness about obesity-related health risks rises globally. With growing concern over lifestyle-related disorders, there is an increasing emphasis on medical intervention as a complement to traditional weight management strategies.…
Fuzzle joins The Obesity Society & The Obesity Action Coalition; Promotes Habit- …
Building healthy, sustainable habits for long-term weight management success.
Tampa, FL - March 18, 2025 - Fuzzle, an emerging leader in the wellness landscape, is pleased to announce that it's now a Member of The Obesity Society, as well as the Obesity Action Coalition, marking a new milestone in the company's mission to transform how individuals approach weight loss.
Image: https://www.globalnewslines.com/uploads/2025/03/77da787ae98a633847c70fc22e2943c7.jpg
Fuzzle supports individuals in their wellness journey through non-invasive, drug-free strategies. With…
Pediatric Obesity Management Market - Healthy Habits for Life: Advancing Pediatr …
Newark, New Castle, USA: The "Pediatric Obesity Management Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Pediatric Obesity Management Market: https://www.growthplusreports.com/report/pediatric-obesity-management-market/8930
This latest report researches the industry structure,…
Anti-Obesity Drugs Market - From Obesity to Vitality: Leading the Way in Effecti …
Newark, New Castle, USA - new report, titled Anti-Obesity Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Anti-Obesity Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Anti-Obesity Drugs market. The report offers an overview of the market, which…
Increasing Prevalence of Obesity Driving Obesity/Bariatric Surgery Devices Marke …
The global obesity/bariatric surgery devices market revenue stood at $1.4 billion in 2016, and it is expected to rise to $2.8 billion by 2023. Furthermore, the market will progress at a CAGR of 9.9% from 2017 to 2023 (forecast period), as per the estimates of the market research company, P&S Intelligence. The major growth drivers of the market are the rising incidence of obesity, owing to unhealthy diets and lifestyle…
Fast Food and Obesity
Most of the fast food in the market contains a large quantity of sugar, #carbs and fats with a lesser quantity of vitamins and minerals. The unhealthy food ingredients in the fast food are further increased with increased portion size. The person will still consume the whole meal regardless of being completely full. People cannot stop ravishing on fast food because it is available for low cost and in close…
